⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players
globenewswire.com
TMO
BIIB
MRK
ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents
globenewswire.com
ALGT
PHG
MASS
WMT
MDLZ
SSTK
SMCI
NVDA
MSFT
GOOG
AMZN
META
IBM
CRM
ADBE
INTC
AMD
MU
QCOM
PANW
SNPS
CDNS
ASML
AMAT
LRCX
KLAC
TER
NXPI
ON
AEHR
PLTR
AI
UPST
SOFI
COIN
MARA
RIOT
PLUG
FCEL
BE
EXAS
REGN
GILD
BIIB
CRSP
ROKU
NFLX
DIS
CMCSA
TTD
SNOW
DDOG
ZS
CRWD
OKTA
SMTC
MCHP
ADI
TXN
MRVL
ALGN
CTAS
PAYX
ADP
CVS
UNH
AMGN
LLY
PFE
MRK
JNJ
BMY
ABBV
VRTX
AZN
NVO
SNY
XOM
CVX
SRE
NEE
DUK
SO
PCG
ED
AEP
ETR
WEC
D
NI
EXC
NRG
CEG
IRBT
GOOGL
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) Market Report 2026: Poised for Transformation Through 2036 as Pegcetacoplan, Iptacopan, and SGB-9768 Advance
globenewswire.com
APLS
BIIB
NVS
Graft Versus Host Disease (GvHD) Market & Epidemiology Forecast 2026-2036 - Set to Reach New Growth Milestones Through 2036 as Targeted, Cell-Based, and Microbiome Therapies Advance
globenewswire.com
ABBV
JNJ
SNY
INCY
SNDX
NVS
BMY
MRK
REGN
GILD
AMGN
BIIB
AZN
Replit ouvre son premier bureau international à Londres
prnewswire.com
MSFT
GOOG
ADBE
ACN
V
Z
NVDA
AMZN
META
IBM
ORCL
CRM
INTC
AMD
QCOM
MU
AMAT
ASML
TXN
ADI
NXPI
LRCX
KLAC
CDNS
SNPS
MCHP
ON
WDC
SE
PLTR
UPST
COIN
BNTX
MRNA
GILD
BMY
AMGN
REGN
LLY
BIIB
VRTX
AZN
XOM
CVX
SHEL
BABA
JD
NTES
PDD
BIDU
MELI
NIO
LI
XPEV
RIVN
TSLA
PLUG
FCEL
SPCE
CRSP
EDIT
NTLA
ALGN
EXAS
TDOC
ROKU
PYPL
HOOD
MARA
RIOT
2026 RNAi Therapeutics Market Report (3rd Edition): Analysis by Type of RNAi Molecule, Therapeutic Area, Route of Administration, Key Geographical Regions, Sales Forecast and Leading Industry Players to 2035
globenewswire.com
ALNY
ARWR
NVO
NVS
BIIB
REGN
GILD
MRK
BMY
ABBV
AMGN
AZN
PFE
SNY
TEVA
BHC
CRSP
EDIT
NTLA
SRPT
SLN
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
globenewswire.com
STOK
BIIB
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16 th European Epilepsy Congress (EEC)
businesswire.com
STOK
BIIB
Ric Burns' Acclaimed NEW YORK: A DOCUMENTARY FILM Returns with Two New Films September 21st and 22nd On PBS
prnewswire.com
AMX
GOOG
CMCSA
IBM
MSFT
NVDA
INTC
META
AMZN
NFLX
ABNB
UBER
LYFT
TSLA
GM
F
RIVN
NIO
XPEV
LI
PLTR
SNOW
CRM
ADBE
GOOGL
MSCI
SPGI
BKNG
EXPE
MAR
H
WYNN
LVS
MGM
CHTR
VZ
T
QCOM
AMD
MU
AMAT
ASML
TXN
NXPI
ON
ADI
LRCX
KLAC
MRVL
WDC
SE
BABA
JD
PDD
BIDU
BILI
IQ
VIPS
HTHT
NTES
EDU
BEKE
RMAX
Z
HOFT
PG
KO
PEP
MCD
SBUX
YUM
CMG
WEN
CAKE
BJRI
EAT
DRI
BLMN
TH
QSR
SONO
BBY
WMT
TGT
HD
LOW
COST
TJX
ROST
M
KSS
URBN
ANF
AEO
LULU
NKE
UA
CROX
RL
PVH
TPR
CPRI
KHC
GIS
CL
EL
ORCL
SAP
ACN
HPQ
DELL
CSCO
INTU
PYPL
AXP
V
MA
JPM
BAC
WFC
C
MS
GS
SCHW
RJF
LPLA
BEN
IVZ
AB
PGR
ALL
TRV
CB
UNM
MET
PRU
AIG
LNC
GL
CCI
AMT
EQIX
DLR
COR
NTAP
STX
WD
CDNS
SNPS
QTRX
REGN
GILD
AMGN
BMY
ABBV
LLY
PFE
MRK
JNJ
BIIB
VRTX
ALKS
AZN
SNY
NVS
CRSP
EDIT
NTLA
BNTX
MRNA
EXAS
ILMN
ROKU
CRWD
COIN
MARA
RIOT
FTFT
BTBT
CLSK
HUT
GLXY
NNDM
IONQ
RIG
NVCR
CRBU
ACRS
APLS
AXSM
CLDX
CRBP
CUE
CYTK
DASH
GRWG
PLUG
FCEL
BE
NEE
DUK
SO
EXC
SRE
PCG
LEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China
globenewswire.com
BIIB